SCHEMBL31549560

SCHEMBL31549560

Cc1ccc(O)c2ccn(C(=O)OC(C)(C)C)c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BUB1 O43683 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ BCHE P06276 1/20 0.36
▸ HTR6 P50406 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ ACLY P53396 1/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ ESR2 Q92731 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.32
▸ POLB P06746 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ TNK2 Q07912 1/20 0.30
▸ EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18486750 0.84 BUB1 (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL18482861 0.84 BUB1 (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL31549571 0.81 BUB1 (0.44) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL19445998 0.79 BUB1 (0.42) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL21625234 0.79 CYP3A4 (0.37) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL31549576 0.78 BUB1 (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL31549582 0.78 ACLY (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL31549631 0.78 BUB1 (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL31549680 0.78 ACLY (0.39) BUB1L3MBTL1BCHEHTR6HSP90AA1
SCHEMBL26128203 0.77 BUB1 (0.40) BUB1L3MBTL1BCHEHTR6HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068951-A1 COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF NOVARTIS AG (CH) 2025-04-03 — — WO disclosed
Send feedback